跳至主要内容
临床试验/NCT04675255
NCT04675255已完成不适用

WU 360: Assessing the Impact of Integrase Strand Transfer Inhibitors (INSTI) to Protease Inhibitor (PI) Switch on Insulin Sensitivity and Fat Metabolism (ADIPOSITY): a Sub-study of DEFINE

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2021年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
Insulin Sensitivity measured by homeostatic model assessment for insulin resistance {HOMA_IR}

研究概览

简要总结

A substudy of TMC114FD2HTX4004 that will perform glucose tolerance testing, adipose testing and MRI scan at baseline, 12 and 24 weeks post switch of ART medications.

详细描述

Synopsis Full study title: Assessing the impact of integrase strand transfer inhibitors (INSTI) to protease inhibitor (PI) switch on insulin sensitivity and fat metabolism (ADIPOSITY): a sub-study of DEFINE

Endpoints and objectives:

The following endpoints will be determined 12 and 24 weeks after switch from an INSTI-based antiretroviral therapy (ART) regimen to a PI-based regimen:

Primary endpoint: Change in insulin sensitivity (SI) at 12 weeks assessed by using a 3-hour frequently sampled oral glucose tolerance testing (fsOGTT).

Secondary endpoints: 1) Change in insulin sensitivity (SI) at 24 weeks assessed by using a 3-hour frequently sampled oral glucose tolerance testing (fsOGTT); 2) Change in insulin secretion during the fsOGTT assessed by using C-peptide deconvolution; 3) Change in intrahepatic triglyceride (IHTG) content measured by magnetic resonance imaging (MRI); 4) Change in adipocyte size by the osmium tetroxide fixation technique; and 5) Change in expression of genes associated with adipose tissue development, lipogenesis, inflammation and endocrine function by RNA sequencing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •• Must be enrolled in the DEFINE study TMC114FD2HTX4004
  • •Must sign an ICF indicating that they understand the purpose of, and procedures required for, the study and are willing to participate in the study.

排除标准

  • •• Contraindication to magnetic resonance imaging as determined by institutional policy.
  • •Current diagnosis of diabetes mellitus

研究组 & 干预措施

Immediate switch

Active Comparator

Immediate switch

干预措施: Frequently sampled glucose tolerance testing (Procedure)

Immediate switch

Active Comparator

Immediate switch

干预措施: abdominal subcutaneous adipose tissue biopsy (Procedure)

Immediate switch

Active Comparator

Immediate switch

干预措施: MRI scan to assess intrahepatic triglyceride content (Procedure)

Delayed switch

Active Comparator

Delayed switch

干预措施: Frequently sampled glucose tolerance testing (Procedure)

Delayed switch

Active Comparator

Delayed switch

干预措施: abdominal subcutaneous adipose tissue biopsy (Procedure)

Delayed switch

Active Comparator

Delayed switch

干预措施: MRI scan to assess intrahepatic triglyceride content (Procedure)

结局指标

主要结局

Insulin Sensitivity measured by homeostatic model assessment for insulin resistance {HOMA_IR}

时间窗: 12 weeks

Change in insulin sensitivity (SI) at 12 weeks assessed by using a 3-hour frequently sampled oral glucose tolerance testing (fsOGTT).to calculate HOMA_IR

次要结局

  • Adipocyte size measured by osmium tetroxide fixation technique(24 weeks)
  • Adipocyte gene expression correlated with adipose tissue development(24 weeks)
  • Insulin Sensitivity measured by homeostatic model assessment for insulin resistance {HOMA_IR}(24 weeks)
  • Intrahepatic triglyceride (IHTG) content measure by magnetic resonance(24 weeks)
  • Intrahepatic triglyceride (IHTG) content measure by magnetic resonance(12 weeks)
  • Adipocyte size measured by osmium tetroxide fixation technique(12 weeks)
  • Adipocyte gene expression correlated with adipose tissue development(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验